Critical Clarity by Design

For clinical trial vendors who need pharma to say yes

We translate clinical trial technology into product direction and commercial positioning that pharma teams trust.

Vendors leave knowing what to build, why it matters under ICH E6(R3), and how to talk about it in rooms where decisions get made.

"Her understanding of the inner mechanisms, incentive structures, and business needs were invaluable for helping align our product and commercial strategy into a focused wedge for the market." - Ellis Hiroki, founder

Free 20-Minute Teaching on

Jan 22nd at 12pm EDT

20 Min Teaching - Can RBQM Work Without Audit Trail Review Analytics (ATRA)?

RBQM needs process insight. ATRA (Audit Trail Review Analytics) provides it.

person staring at screen of ones and zeros

Is Your Audit Trail Just a Log — Or a Powerful Risk Management Tool?

Audit Trail Analytics – From Records to Real Insights

Learn More
person staring at screen of ones and zeros
quality control
quality control

Are You Ready for ICH E6(R3)? Build a Smarter Approach to Risk-Based Monitoring.

Risk-Based Quality Management (RBQM) Implementation

microscope

Building Pharma Solutions? Are They Scalable, Practical, and Built to Last?

Solution Consulting & Implementation

microscope
Nechama Katan
Nechama Katan

Want to Elevate the Conversation? Book a Speaker Who Brings Insight and Impact.

Speaking Engagements & Training

Want to solve the impossible and turn chaos into clarity?

The Wizard's Library

Where Wicked Problems in Clinical Trials Meet Their Match

  • ICH E6(R3) – Good Clinical Practice Guideline (2025)


    The latest GCP guideline from ICH, E6(R3) emphasizes risk-based quality management, audit trail analytics, and proportionate approaches to trial oversight. A must-read for understanding evolving regulatory expectations in modern clinical trials.

  • Wicked Problems (CogNexus)

    Wicked problems are complex, shifting challenges with no single solution, no clear endpoint, and no definitive test of success. Each attempt to solve them changes the problem itself. This classic paper lays the foundation for understanding wicked problems—and why they require collaborative, adaptive, and systems-based approaches rather than linear thinking.

  • ICH E8(R1) – General Considerations for Clinical Studies (2021)

    This updated guideline reframes quality in clinical trials by promoting a culture of trust, open dialogue, and critical thinking. It moves away from rigid, checklist-driven approaches, advocating instead for risk-proportionate planning and engagement of stakeholders, including patients. A foundational read for anyone designing studies with integrity, relevance, and operational excellence in mind.